SCOTUS cannabis & guns case gets delay request (Newsletter: October 24, 2025)

October 24, 2025

Marijuana as alcohol alternative is no longer a whisper in dimly lit bars; it’s the bass line rattling the back of the house, changing what we drink, how we unwind, and who gets paid. When a major whiskey outfit says it’s trimming operations because customers are drinking less and turning to cannabis, that’s not a blip—it’s a cultural pivot. The “sober-curious” wave met the legal cannabis era, and together they remixed America’s nightcap. For a gut-check on how this shift plays out in boardrooms and bottle shops, start with Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative. Behind the press releases, you can hear the gears grinding: less whiskey poured, more flower rolled, and a growing market of drinkers choosing THC over ABV. That’s the cannabis industry impact in plain English—taste, health, and habit colliding with profit.

Follow the money, sure, but follow the body too. A new wave of research is painting a complicated picture: cannabis use is associated with lower risk of alcohol-associated liver disease, fewer liver complications, and even reduced mortality compared to non-users. Read that again—associated, not proven causal—but it’s a data point you feel in your ribs. The loudest signal shows up among heavy consumers, the very people tagged with “cannabis use disorder.” It’s messy and it challenges old dogmas. It hints at a public health ledger where cannabis doesn’t just compete with alcohol—it may blunt some of alcohol’s worst edges. For a nation paying dearly for liver disease, the implications aren’t academic. They’re kitchen-table real: choices at checkout shaping outcomes in the ICU. In that light, marijuana policy reform becomes more than rhetoric; it’s a health strategy, a budgeting question, a moral call about what harms we tolerate and which exits we build.

Meanwhile, the other frontier—psychedelics—is swapping hype for homework. Ohio just put real skin in the game, funding training so cops, EMTs, and clinicians can recognize and manage bad trips before they spiral. That’s not a culture war; that’s harm reduction wearing a reflective vest. It signals policymakers finally understand that the psychedelic conversation doesn’t start in a lab and end at a ballot box—it lives in patrol cars, ER bays, and counseling rooms at 2 a.m. For the blueprint, watch the public health playbook in Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More. This is the practical side of reform: fewer panics, better protocols, safer communities. It’s not sexy, but it’s the scaffolding that keeps the house from falling down when trends become realities.

Of course, the law moves like molasses in January. The Supreme Court now has a marijuana-and-gun-rights case on its plate, with the Justice Department asking for extra time to file. On one side: millions of state-legal cannabis consumers wondering why a single honest admission about their weekend gummy should cost them their Second Amendment rights. On the other: a federal system aging badly, creaking under rules written for a different century. The docket tells you where we are—halfway between stigma and sanity—while headlines ping-pong between “public safety” and “personal liberty.” Track the stakes in Trump DOJ Asks Supreme Court For Delayed Schedule In Case On Marijuana Users’ Gun Rights. And if you want a bonus exhibit in federal-cannabis limbo, consider states sitting on piles of legal cannabis revenue because someone in D.C. can’t say the word “modernize.” Cannabis taxation without fully functional governance—sounds about right.

Politics, naturally, prefers platitudes to hard choices. Voters keep asking for adult-use access, equity, safer products, and clearer rules, and too many candidates answer with a shrug. In New Jersey, the race for governor is a master class in sidestepping consumers who just want a fair, functioning market and the civil rights that go with it. If they’re serious about public safety, budgets, and justice, they need to talk like it—and legislate like it. For what that accountability should look like, start here: New Jersey Gubernatorial Candidates Need To Step Up For Cannabis Consumers (Op-Ed). The market’s already speaking—less bourbon, more bud; fewer ER scares, better training; courts inching toward coherence. The question is whether leaders will keep up, or keep hiding. And if you’re ready to chart your own course in this changing landscape, explore the good stuff where quality meets calm: our shop.

Leave a Reply

Subscribe

Get Weekly Discounts & 15% Off Your 1st Order.

    FDA disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

    Please Note: Due to current state laws, we are unable to ship THCa products to the following states: Arkansas, Idaho, Minnesota, Oregon, Rhode Island.
    Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
    • Image
    • SKU
    • Rating
    • Price
    • Stock
    • Availability
    • Add to cart
    • Description
    • Content
    • Weight
    • Dimensions
    • Additional information
    Click outside to hide the comparison bar
    Compare
    Home
    Shopping
    Account